{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:10:02Z","timestamp":1791155402290,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4,15]]},"DOI":"10.1097\/qai.0b013e3181bc476f","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:34:33Z","timestamp":1268890473000},"page":"589-597","source":"Crossref","is-referenced-by-count":72,"title":["Predictors of Immune Reconstitution Inflammatory Syndrome\u2013Associated With Kaposi Sarcoma in Mozambique: A Prospective Study"],"prefix":"10.1097","volume":"53","author":[{"given":"Emilio","family":"Letang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene E","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tacilta","family":"Nhampossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Naniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-1601-9_1","article-title":"Epidemiology of HIV-associated malignancies.","volume":"104","author":"Dal Maso","year":"2001","journal-title":"Cancer Treat Res"},{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.bjc.6604520","article-title":"Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.","volume":"99","author":"Franceschi","year":"2008","journal-title":"Br J Cancer"},{"key":"R3-5-20210131","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200307250-00001","article-title":"A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposis sarcoma.","volume":"17","author":"Portsmouth","year":"2003","journal-title":"AIDS"},{"key":"R4-5-20210131","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2005.05.4072","article-title":"Differential impact of combination antiretroviral therapy in preventing Kaposis sarcoma with and without visceral involvement.","volume":"24","author":"Grabar","year":"2006","journal-title":"J Clin Oncol"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","article-title":"Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.","volume":"18","author":"Bourboulia","year":"2004","journal-title":"AIDS"},{"key":"R6-5-20210131","first-page":"13","article-title":"Management of Kaposis sarcoma in resource-limited settings in the era of HAART.","volume":"7","author":"Lynen","year":"2005","journal-title":"AIDS Rev"},{"key":"R7-5-20210131","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e328182df03","article-title":"Kaposis sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART\/chemotherapy in HIV clade C-infected individuals with Kaposis sarcoma.","volume":"21","author":"Bihl","year":"2007","journal-title":"AIDS"},{"key":"R8-5-20210131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-3156.2005.01491.x","article-title":"AIDS-related Kaposis sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.","volume":"10","author":"Sissolak","year":"2005","journal-title":"Trop Med Int Health"},{"key":"R9-5-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6600745","article-title":"Review of the distribution of Kaposis sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposis sarcoma.","volume":"88","author":"Dedicoat","year":"2003","journal-title":"Br J Cancer"},{"key":"R10-5-20210131","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00002030-199907090-00004","article-title":"Variability and evolution of Kaposis sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group.","volume":"13","author":"Cook","year":"1999","journal-title":"AIDS"},{"key":"R11-5-20210131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"3rd, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","article-title":"Immune restoration disease after antiretroviral therapy.","volume":"18","author":"French","year":"2004","journal-title":"AIDS"},{"key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.","volume":"22","author":"Murdoch","year":"2008","journal-title":"AIDS"},{"key":"R15-5-20210131","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2004-831880","article-title":"Pulmonary Kaposis sarcoma in pregnancy.","volume":"21","author":"Bryant","year":"2004","journal-title":"Am J Perinatol"},{"key":"R16-5-20210131","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1086\/426078","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.","volume":"39","author":"Connick","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R17-5-20210131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1258\/0956462052932647","article-title":"Fatal Kaposis sarcoma-associated immune reconstitution following HAART initiation.","volume":"16","author":"Crane","year":"2005","journal-title":"Int J STD AIDS"},{"key":"R18-5-20210131","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1258\/095646206778145668","article-title":"Timing of highly active antiretroviral therapy and chemotherapy for Kaposis sarcoma in patients with HIV infection.","volume":"17","author":"Loke","year":"2006","journal-title":"Int J STD AIDS"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/QAD.0b013e3280ad3da6","article-title":"Suspected immune reconstitution inflammatory syndrome associated with the proliferation of Kaposis sarcoma during HAART.","volume":"21","author":"Nathan","year":"2007","journal-title":"AIDS"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1902\/jop.2008.070225","article-title":"Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report.","volume":"79","author":"Feller","year":"2008","journal-title":"J Periodontol"},{"key":"R21-5-20210131","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/apc.2005.19.635","article-title":"Recrudescent Kaposis sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.","volume":"19","author":"Leidner","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"R22-5-20210131","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1200\/JCO.2005.14.597","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposis sarcoma.","volume":"23","author":"Bower","year":"2005","journal-title":"J Clin Oncol"},{"key":"R23-5-20210131","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JCM.01264-06","article-title":"Comparative study of Kaposis sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis.","volume":"45","author":"Nascimento","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R24-5-20210131","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JCM.38.5.1992-1995.2000","article-title":"Quantitation of cell-free and cell-associated Kaposis sarcoma-associated herpesvirus DNA by real-time PCR.","volume":"38","author":"White","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R25-5-20210131","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposis sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1097\/QAD.0b013e3283121ca9","article-title":"Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.","volume":"22","author":"Nash","year":"2008","journal-title":"AIDS"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/j.jinf.2005.02.031","article-title":"Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.","volume":"51","author":"Skiest","year":"2005","journal-title":"J Infect"},{"key":"R29-5-20210131","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/COH.0b013e328302cc3d","article-title":"Ocular immune reconstitution inflammatory syndromes.","volume":"3","author":"Otiti-Sengeri","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tripleo.2006.08.015","article-title":"HIV-associated Kaposi sarcoma: pathogenic mechanisms.","volume":"104","author":"Feller","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R31-5-20210131","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V93.12.4031.412a37_4031_4033","article-title":"Inflammatory reactivation and angiogenicity of Kaposis sarcoma-associated herpesvirus\/HHV8: a missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposis sarcoma.","volume":"93","author":"Mesri","year":"1999","journal-title":"Blood"},{"key":"R32-5-20210131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.pathol.1.110304.100133","article-title":"KSHV infection and the pathogenesis of Kaposis sarcoma.","volume":"1","author":"Ganem","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"R33-5-20210131","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(03)01192-6","article-title":"Use of HIV protease inhibitors to block Kaposis sarcoma and tumour growth.","volume":"4","author":"Sgadari","year":"2003","journal-title":"Lancet Oncol"},{"key":"R34-5-20210131","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/428618","article-title":"3rd, Darcourt J, White AC Jr, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy.","volume":"40","author":"Shelburne","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R35-5-20210131","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00002030-200009290-00006","article-title":"Relationship of human herpesvirus 8 peripheral blood virus load and Kaposis sarcoma clinical stage.","volume":"14","author":"Campbell","year":"2000","journal-title":"AIDS"},{"key":"R36-5-20210131","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1086\/374599","article-title":"Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.","volume":"36","author":"Campbell","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R37-5-20210131","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/QAD.0b013e3282fc9c03","article-title":"Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.","volume":"22","author":"El Amari","year":"2008","journal-title":"AIDS"},{"key":"R38-5-20210131","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1074\/jbc.M011314200","article-title":"Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1.","volume":"276","author":"Huang","year":"2001","journal-title":"J Biol Chem"},{"key":"R39-5-20210131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1011991906685","article-title":"HIV-Tat dependent chemotaxis and invasion, key aspects of tat mediated pathogenesis.","volume":"18","author":"Vene","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"R40-5-20210131","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/503903","article-title":"Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy.","volume":"42","author":"Robertson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R41-5-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","article-title":"Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.","volume":"1","author":"French","year":"2000","journal-title":"HIV Med"},{"key":"R42-5-20210131","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1468-1293.2005.00277.x","article-title":"The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.","volume":"6","author":"Jevtovic","year":"2005","journal-title":"HIV Med"},{"key":"R43-5-20210131","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","article-title":"Immune reconstitution inflammatory syndrome: risk factors and treatment implications.","volume":"46","author":"Manabe","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R44-5-20210131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/aid.2007.0134","article-title":"Rapid spread and genetic diversification of HIV type 1 subtype C in a rural area of southern Mozambique.","volume":"24","author":"Lahuerta","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R45-5-20210131","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00705-008-0215-6","article-title":"Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique.","volume":"153","author":"Abreu","year":"2008","journal-title":"Arch Virol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e3181bc476f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:22Z","timestamp":1786040122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201004150-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,15]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181bc476f","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3018961.2703068","asserted-by":"object"}]},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4,15]]}}}